Page last updated: 2024-11-02

oxidopamine and Cytomegalovirus

oxidopamine has been researched along with Cytomegalovirus in 3 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Cytomegalovirus: A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, CT1
Chau, KY1
Schapira, AH1
Kaplitt, MG1
Leone, P1
Samulski, RJ1
Xiao, X1
Pfaff, DW1
O'Malley, KL1
During, MJ1
Mandel, RJ1
Snyder, RO1
Leff, SE1

Other Studies

3 other studies available for oxidopamine and Cytomegalovirus

ArticleYear
The Cytomegalovirus protein pUL37×1 targets mitochondria to mediate neuroprotection.
    Scientific reports, 2016, 08-26, Volume: 6

    Topics: Animals; bcl-2-Associated X Protein; Cell Line; Cytomegalovirus; Exons; Glycolysis; Humans; Immediat

2016
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.
    Nature genetics, 1994, Volume: 8, Issue:2

    Topics: Adenoviruses, Human; Animals; Apomorphine; Behavior, Animal; beta-Galactosidase; Brain; Corpus Stria

1994
Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.
    Experimental neurology, 1999, Volume: 160, Issue:1

    Topics: Animals; Cytomegalovirus; Dependovirus; Dopamine; Genes, Reporter; Genetic Therapy; Genetic Vectors;

1999